Novartis AG (NVS)
103.84
+0.74
(+0.72%)
USD |
NYSE |
Nov 21, 16:00
103.80
-0.04
(-0.03%)
After-Hours: 20:00
Novartis Price to Book Value: 4.792 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 20, 2024 | 4.758 |
| November 19, 2024 | 4.766 |
| November 18, 2024 | 4.756 |
| November 15, 2024 | 4.757 |
| November 14, 2024 | 4.772 |
| November 13, 2024 | 4.794 |
| November 12, 2024 | 4.842 |
| November 11, 2024 | 4.877 |
| November 08, 2024 | 4.913 |
| November 07, 2024 | 4.942 |
| November 06, 2024 | 4.930 |
| November 05, 2024 | 5.048 |
| November 04, 2024 | 5.101 |
| November 01, 2024 | 5.047 |
| October 31, 2024 | 5.003 |
| October 30, 2024 | 5.073 |
| October 29, 2024 | 5.101 |
| October 28, 2024 | 5.337 |
| October 25, 2024 | 5.252 |
| October 24, 2024 | 5.221 |
| October 23, 2024 | 5.265 |
| October 22, 2024 | 5.276 |
| October 21, 2024 | 5.341 |
| October 18, 2024 | 5.408 |
| October 17, 2024 | 5.377 |
| Date | Value |
|---|---|
| October 16, 2024 | 5.380 |
| October 15, 2024 | 5.364 |
| October 14, 2024 | 5.368 |
| October 11, 2024 | 5.364 |
| October 10, 2024 | 5.299 |
| October 09, 2024 | 5.337 |
| October 08, 2024 | 5.251 |
| October 07, 2024 | 5.255 |
| October 04, 2024 | 5.259 |
| October 03, 2024 | 5.251 |
| October 02, 2024 | 5.283 |
| October 01, 2024 | 5.287 |
| September 30, 2024 | 5.309 |
| September 27, 2024 | 5.609 |
| September 26, 2024 | 5.609 |
| September 25, 2024 | 5.648 |
| September 24, 2024 | 5.648 |
| September 23, 2024 | 5.645 |
| September 20, 2024 | 5.625 |
| September 19, 2024 | 5.626 |
| September 18, 2024 | 5.626 |
| September 17, 2024 | 5.613 |
| September 16, 2024 | 5.674 |
| September 13, 2024 | 5.611 |
| September 12, 2024 | 5.614 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.449
Minimum
Sep 26 2022
5.865
Maximum
Aug 30 2024
3.729
Average
3.603
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 4.892 |
| Johnson & Johnson | 5.336 |
| Eli Lilly and Co | 49.99 |
| Novo Nordisk AS | 25.26 |
| Monte Rosa Therapeutics Inc | 2.506 |
Price to Book Value Related Metrics
| PE Ratio | 12.17 |
| PS Ratio | 4.264 |
| PEG Ratio | 0.0942 |
| Price to Free Cash Flow | 17.03 |
| Price | 103.84 |
| Earnings Yield | 8.21% |
| Market Cap | 207.59B |
| PEGY Ratio | 0.0916 |
| Operating PE Ratio | 15.66 |
| Normalized PE Ratio | 18.09 |